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EXTENDED ABSTRACT
Introduction
Present-day  era  of  Big  Data  provides  the  unique
opportunity  to  develop  innovative  approaches  for  data
analysis  to  find  new  insights  into  specialized  fields  of
biomedical  research  such  as  Precision  Medicine  [1].
Precision Medicine is defined as the integration of molecular
research with clinical data in order to deliver better diagnoses
and  treatments  tailored  to  the  individual  characteristics  of
each patient. Advanced analysis of health related data that is
specific  to  a  given  individual  must  focus  on  both  clinical
information  (e.g.  clinical  reports,  medical  images,  patient
histories)  and  biological  data  (e.g.  gene  and  protein
sequences,  functions  and  pathways).  This  wealth  of
information has the potential  to inspire systematic  ways  of
making sense from the massive and heterogeneous stream of
data  and  providing  a  unified  view.  In  the  regards,  Deep
Learning (DL) [2] and  Cognitive Computing  (CC) [3] are
two  branches  of  Artificial  Intelligence  (AI)  representing
convenient  choices  to  tackle  the  problem  of  Big  Data
integration  for  Precision  Medicine.  DL comprises  several
machine  learning  techniques  modeling  multiple
representations  of  data  through  many  layers  of  nonlinear
processing units.  CC is  a  cross-disciplinary technology for
adaptive  and  contextual  knowledge  representation  and
reasoning  through  sophisticated  analytics  aiming  to  mimic
human learning mechanisms.
Objectives
1 - Ontologies of molecular and clinical annotations
A large fraction of biological  knowledge is organized in
the form of ontologies, i.e. sets of domain-specific categories
(terms)  with  relations  operating  among  them.  The  Gene
Ontology  (GO)  [3]  covers  three  domains:  cellular
components,  biological  processes  and  molecular  functions.
The  Human  Phenotype  Ontology  (HPO)  [4]  covers  the
domain of  clinical signs or phenotypic anomalies in human
diseases. Inspired by automatic language translation, specific
Deep Learning approaches like “encoder-decoder” Recurrent
Neural  Networks  (RNNs)  with  Long  Short-Term  Memory
(LSTM) architecture and Attention Mechanism (AM) (Fig. 1)
can be used to model the “translation” of one ontology to the
other  and  build  a  common  function-disease  reference
framework.  In  the  context  of  Personalized  Medicine,  this
approach  can  be  exerted  to  understand  the  relationships
between  the  genetic  variants  found in  a  given  patient  and
her/his  specific  set  of  disease-associated  phenotypes  and
altered gene functions and pathways.
2 – Genotype-phenotype relationships
A  compelling  application  of  RNNs  techniques  is  to
uncover  of  the determinants  of  time-dependent biological
processes such as cellular differentiation. Recently,  Carrillo
de Santa Pau et al. [5] proposed a model to link epigenetic
signatures to cell fate during hematopoiesis, i.e. the process
of formation of blood cellular components starting from stem
cells in the red bone marrow (Fig. 2). Along with changes in
the  epigenome,  additional  ‘omics’  data  (e.g.  chromatin
conformations, expression levels, protein abundances)  can be
taken into account to model complex time series by means of
deep  RNNs.  In  the  context  of  Personalized  Medicine,  this
approach can be applied to the detection of patient specific
disease related (epi)genomics modifications affecting cellular
Fig. 1: Schematic view of Enconder-Decoder RNN that 
takes a Clinical annotation as an input and produces the 
correponding Molecular annotation as an output.
Fig. 2: Genome segmentation in 5 chromatin states across 
samples (upper panel). Changes of chromatine states 
between differentiation stages (lower panel; line thickness 
is proportinal to the number of regions) (adapted from 
Carillo de Santa Pau 2016 [5]).
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differentiation processes and will be potentially applicable to
tumor evolution processes. 
3 – Cognitive computing with IBM Watson
IBM  Watson (http://www.research.ibm.com/cognitive-
computing/) [6] is one of the most advanced AI-platform for
CC.  This  technology  differs  from  current  computing
applications in that it moves beyond pre-configured rules as it
reasons  based  on  broad  objectives.  IBM  Watson  system  is
adaptive, interactive, stateful and contextual, meaning that it
learns as information changes by asking questions and finding
additional inputs based on user’s needs at that point in time
and  from  different  sources  of  information  (syntax,  domain
regulations, etc.). As a result, IBM Watson is able to addresses
complex  situations  that  are  characterized  by  ambiguity  and
uncertainty such as question answering (QA) tasks based on
large unstructured collections of natural language documents.
In  collaboration  with  IBM  we  are  applying  Cognitive
Computing  approaches  to  the  above  mentioned  scenario
relating (epi)genome-phenome/disease information sources. 
Discussion
In  recent  years,  many  AI  techniques  emerged  that  can
effectively learn from for  very large  and complex data sets
achieving  human-level  performances  in  image  and  speech
recognition  as  well  as  natural  language  processing.
Incorporating  biomedical  knowledge  into  such  a  new
generation of learning algorithms is the current paradigm in
biomedical  research.  Indeed,  the development of algorithms
for  a  comprehensive  analysis  of  health-related  Big  Data
represents one of the main challenges for the Computational
Biology community and also a rational  aid to  experimental
scientists  and  physicians.  In  particular,  DL  such  as  deep
RNNs,  and  CC  such  as  IBM  Watson  system,  offer  the
possibility  to  address  Personalized  Medicine  problems
prompting functional hypotheses and guiding better diagnoses
and  treatments.  Multiple  data  sources,  namely  large-scale
clinical and molecular data, combined into integrative models
designed to reveal unexpected relationships among biological
entities  will  help  to  unveil  the  broader  context  in  which
physiological and pathological events are occurring.
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